ArticleJournal of clinical immunology2004

A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.

Dror Luger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.